Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

How Drug Manufacturers Are Impacting The Death Penalty Debate

March 24, 2015 11:22 am | by Meagan Parrish, Editor, Chem.Info | Articles | Comments

Polls generally show that the majority of Americans are on board with the death penalty. In October 2014, Gallup reported that 63 percent of Americans were in favor of capital punishment while 33 percent were opposed.

TOPICS:

GOP Hits Medicaid to Offset Doctor Fee Hikes

March 24, 2015 8:35 am | by DAVID ESPO, AP Special Correspondent | News | Comments

House Republicans quietly deepened recommended budget savings from the government's chief health care program for the poor by about $140 billion in recent weeks to offset part of the cost of higher payments to doctors who treat Medicare patients, according to officials familiar with the tradeoff.

TOPICS:

Multiple Canadian Provinces to Provide Public Funding for Gilead's Harvoni™

March 24, 2015 8:26 am | News | Comments

Gilead Sciences Canada today announced that multiple provinces will provide public access to Harvoni ™ (ledipasvir/sofosbuvir), the first once-daily, single tablet regimen for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection in adults.

TOPICS:
Advertisement

BMS Acquires Exclusive License from Novo Nordisk for a Discovery Research Program Focused on Autoimmune Diseases

March 24, 2015 8:16 am | News | Comments

Bristol-Myers Squibb Company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases.

TOPICS:

HHS Seeks to Develop Improved Anthrax Vaccine

March 24, 2015 8:08 am | News | Comments

Advanced development is underway on an improved anthrax vaccine that could provide protection in fewer doses than the currently licensed anthrax vaccine and so may be more cost-effective to stockpile.

TOPICS:

FDA Warns Cosmetics Companies Against Promises That 'Go Too Far'

March 24, 2015 8:04 am | by Andy Szal, Digital Reporter | News | Comments

The agency said its tracking of claims by cosmetics companies during recent years indicated a proliferation in drugs claims--defined by the FDA as "intended to treat or prevent disease, or change the body’s structure or functions"--on product packaging and in web advertising.

TOPICS:

Handheld Formaldehyde Meter/Monitor

March 23, 2015 5:07 pm | by New Star Environmental, Inc. | Product Releases | Comments

The HFX205 Formaldehyde Monitor designed for use in a wide variety of applications such as furniture, floorboards, wallpapers, paint, gardening, indoor decorations, construction, dye stuffs, paper manufacture, pharmaceutical, medical, food, cleaning, synthetic resins, textile treatment, horticulture and cosmetics.

Bioprocessing Facilities: New Technologies Are Driving a Deeper Understanding of the Entire Process

March 23, 2015 4:26 pm | by Tom Piombino, Process Architect - IPS-Integrated Project Services, Inc. | Blogs | Comments

While most architecture in the world is devoted to creating environments for human occupancy, who is tasked with designing facilities that manufacture drug products to occupy humans?

TOPICS:
Advertisement

Material Airlocks: Welcome to the 21st Century

March 23, 2015 4:21 pm | by Jerrod Shook, Director, Aseptic Processing Technology IPS-Integrated Project Services, Inc. | Blogs | Comments

In recent years, new technology has provided a number of significant improvements to aseptic processing facilities.

TOPICS:

WHO Denies Politics Swayed Ebola Emergency Declaration

March 23, 2015 4:14 pm | by MARIA CHENG, Associated Press; RAPHAEL SATTER, Associated Press | News | Comments

The World Health Organization denied that politics swayed the decision to declare an international emergency over the spread of the Ebola virus last year, despite evidence senior staffers repeatedly discussed the diplomatic and economic fallout of such a move.

TOPICS:

ImmunoGen Lands Licensing Deal with Takeda

March 23, 2015 4:08 pm | by The Associated Press | News | Comments

Takeda will use ImmunoGen's technology to develop cancer treatments. ImmunoGen will get $20 million upfront and is eligible for milestone payments potentially totaling up to $210 million, plus royalties on sales.

TOPICS:

Teva Announces New Head of Business Development, Strategy and Innovation

March 23, 2015 4:05 pm | News | Comments

Teva Pharmaceutical Industries has announced the appointment of Timothy R. Wright to the Company’s executive leadership team, heading business development, strategy and innovation.

TOPICS:

Robert Kennedy Jr. Speaks Out Against Vaccine Requirements

March 23, 2015 4:02 pm | by MICHAEL CATALINI, Associated Press | News | Comments

Calling the federal agency that oversees vaccines a "sock puppet" for that industry, Robert Kennedy Jr. spoke out Monday in favor of allowing parents to choose whether to vaccinate their children.

TOPICS:

Single Use Disposables: Risk Reduction AND Operational Flexibility – Too Good to be True?

March 23, 2015 8:59 am | by Robert Roy, IPS | Blogs | Comments

The past several years have witnessed a significant increase in the rate of adoption for single use disposable systems for aseptic fill/finish applications.  Paralleling recent advances in flexible aseptic filling lines, single-use disposable systems (SUDS) for aseptic fill/finish facilities promise increased flexibility and streamlined operations.

TOPICS:

Liberians Overcome Fear to Volunteer for Ebola Vaccine Trial

March 23, 2015 8:50 am | by JONATHAN PAYE-LAYLEH, Associated Press | News | Comments

Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading